Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-029978

Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)

  • Sr VP/Chief Commercial Officer gave up 794 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2015-03-27 Grant or award +3,000 $6.86 $20,580 130,700 D
Cearnal Martin E Sr VP/Chief Commercial Officer 2015-03-27 Shares withheld for taxes −794 $6.88 $5,463 129,906 D
Loading xslF345X03/doc4.xml…